Analysts think ARTL stock price could increase by 282%
Jun 14, 2024, 6:28 AM
-1.12%
What does ARTL do
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company based in Solana Beach, California, specializes in developing therapeutics targeting lipid-signaling pathways such as the endocannabinoid system. Key projects include ART27.13, aimed at treating anorexia in cancer, and ART26.12, a candidate for cancer, pain, inflammation, and anxiety disorders, with an IPO launched in 2015.
5 analysts think ARTL stock price will increase by 282.02%. The current median analyst target is $5.10 compared to a current stock price of $1.33. The lowest analysts target is $5.05 and the highest analyst target is $42.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
